World Leaders Recommit to Immunisation Amid Global Funding Shortfall
At the Global Summit: Health and Prosperity through Immunisation in Brussels, world leaders pledged support for Gavi, the Vaccine Alliance, leading to a total of... Read more.
Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary endpoint of overall... Read more.
Dubai Hosts the 6th Edition of the Middle East, Africa and Russia Hematology Summit “MASH”
The Hematology Medical Conference, sponsored by AbbVie, the global research and development company in the field of biopharmaceuticals, kicked off for the sixth... Read more.
2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development of lenacapavir, a medication used to... Read more.
Suriname Certified Malaria-free by WHO
Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO). This historic milestone follows... Read more.
Danaher Appoints Martin Stumpe as Chief Technology and AI Officer
Danaher Corporation, a leading global life sciences and diagnostics innovator, announced that Martin Stumpe will be appointed Chief Technology and AI Officer,... Read more.
IFRC Calls for Increased International Support as Afghan Population Movement from Iran Intensifies
The Islam Qala border crossing in western Afghanistan has seen more than 800,000 people from Afghanistan returning from Iran since January 2025. In June alone,... Read more.
Kyverna Therapeutics Announces Appointment of New Chief Financial Officer
Kyverna Therapeutics, a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced the appointment... Read more.
From Skin Types to Chronic Conditions: Dr. Jawaher Al Naqbi | AIDA 2025
Dr. Jaher expressed particular excitement about the conference’s focus on biologics, JAK inhibitors, and new medications for autoimmune diseases. This includes... Read more.
Merck to Host Investor Event Highlighting Advances in HIV Treatment and Prevention Pipeline
Merck, known as MSD outside of the United States and Canada, announced that scientific and commercial team leaders will host a virtual investor event where they... Read more.
